Omega Alpha SPAC
Status: Liquidated
U=S
| IPO Proceeds, $M | $138.00M |
|---|---|
| IPO Date | Jan 7, 2021 |
| CEO | Otello Stampacchia, PhD |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Healthcare or healthcare-related industries |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
| Closing Date | Dec 28, 2022 |
OMEG
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Omega Alpha SPAC:
- Structure and cap table
- 8 directors & officers
- 6 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Otello Stampacchia, PhD | 51 | CEO and Chairman |
| Michelle Doig | 47 | President and Director |
| Francesco Draetta, CFA, FRM, CAIA | 36 | CFO |
| Vincent Ossipow, PhD, CFA | 52 | Chief Scientific Officer |
| Daniel Lynch | 62 | Director |
| Jan van de Winkel, PhD | 59 | Director |
| Martin Babler | 56 | Director |
| Joseph Slattery | 55 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Jefferies | Joint BR | 6,600,000 | units |
| Morgan Stanley | Joint BR | 5,400,000 | |
| 12,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 6 filings.